SHANGHAI, Oct. 13, 2025 /PRNewswire/ -- Thousand Oaks Biologics' antibody-drug conjugate (ADC) manufacturing site successfully passed an audit conducted by a European Union Qualified Person (QP) and formally received a QP Declaration. This milestone
This decision was the result of the combination of the development of the Chinese pharmaceutical industry as well as my personal industry experience. I returned to China from the US at the end of 2010 because I could see the transformation of the Chi